α1AT as a major plasma glycoprotein with three reported glycosylation sites [46] has had its core fucosylated form [47] also specifically shown to have altered modification patterns that are highly sensitive and specific to HCC and or LC [48]. Here, SERPINA1 is linked to hepatocellular carcinoma.